1998
DOI: 10.1007/s003300050611
|View full text |Cite
|
Sign up to set email alerts
|

CT and MRI appearances of a thoracic chordoma

Abstract: A case of a chordoma in the thoracic spine is presented. This is a very rare tumour in this location and should be considered in the differential diagnosis of any posterior mediastinal mass. The appearances on CT and MRI were similar to chordomas described in other locations. On T2-weighted images septae of low signal intensity radiated throughout the large high-signal mass. This feature may be of use in differentiating chordomas from other posterior mediastinal masses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2003
2003
2012
2012

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(16 citation statements)
references
References 8 publications
0
16
0
Order By: Relevance
“…These septa have been reported in 70% of chordomas and are characteristic features of chordomas. 24 However, we only found these in 2 of 5 patients. Four cases of chordoma demonstrated mild to moderate enhancement after contrast material injection.…”
Section: Discussionmentioning
confidence: 59%
“…These septa have been reported in 70% of chordomas and are characteristic features of chordomas. 24 However, we only found these in 2 of 5 patients. Four cases of chordoma demonstrated mild to moderate enhancement after contrast material injection.…”
Section: Discussionmentioning
confidence: 59%
“…The initial symptoms of thoracic chordoma are subtle and nonspecific. Usually, symptoms are seen with spinal cord compression or thoracic viscera compression (1,9,11,15). The second tumor of our case was at the thoracal region, T3 level.…”
Section: Discussionmentioning
confidence: 67%
“…En bloc spondylectomy and even intralesional resection however are not devoid of complications. Of the 15 reported cases that detail outcomes, 2 died from perioperative complications [13,15]. As always, the balance between treatment morbidity and long-term disease control must be carefully discussed with the patient.…”
Section: Discussionmentioning
confidence: 99%